# FDA Clears Neurovalens Modius Spero as First Neurostimulation Device for PTSD

> fda · REPORTED · 2026-07-01

Neurovalens received FDA clearance for Modius Spero, the first neurostimulation device approved for post-traumatic stress disorder treatment. The device is set to become available to veterans through the VA system beginning summer 2026.

About Neurovalens: Neurovalens is a medical device company that develops non-invasive neurostimulation wearables targeting the vestibular nerve to treat neurological and psychiatric conditions, including PTSD and metabolic disorders.

- Company: Neurovalens
- Sector: medical devices
- Primary source: https://www.medindexer.com/news

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.